Table 3

Disease activity and physical performance tests measured at baseline (T0), end of intervention (T1), and 12 weeks follow-up (T2) (n = 13)

T0

T1

p-value (T0-T1)

T2

p-value (T0-T2)


Disease activity

DAS28

4.7 (2.2-6.7)

4.1 (1.1 - 6.0)

0.04

4.7 (0.8-6.5)

0.24

No. swollen joints (0-28)

11 (2 - 20)

7 (0 - 17)

0.01

5 (0 - 14)

0.02

No. tender joints (0-28)

8 (1 - 29)

4 (0 - 22)

0.22

9 (0 - 20)

0.40

Patient global assessment (0-100)

31 (1 - 51)

21 (1 - 45)

0.67

43 (6 - 61)

0.39

Doctor global assessment (0-100)

32 (19 - 72)

26 (3 -57)

0.08

34 (0 - 55)

0.42

Physical performance test

Figure-of-Eight balance

2.5 (0 - 12)

4 (0-11)

0.24

2.5 (0 - 10)

0.88

Timed-Stands Test (sec)

23 (13 - 34)

15 (10 - 26)

0.01

16 (10 - 28)

< 0.01

Shoulder Movement Impact Scale (0-60)

59 (46 - 60)

59 (46 - 60)

0.10

59 (41 - 60)

0.08

Pain during SMIS (0-100)

8 (0 - 34)

4 (0 - 22)

0.06

10 (0 -19)

0.70


Values are median (range)

DAS28 = Disease activity score

Uhlig et al. BMC Musculoskeletal Disorders 2010 11:43   doi:10.1186/1471-2474-11-43

Open Data